Penumbra Retained Earnings 2011-2026 | PEN

Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.

Possible uses include

reinvestment in development (R&D, equipment, marketing)
debt repayment
acquisition of other companies
creation of reserves for the future

A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.

The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.

Annual Retained Earnings Penumbra

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
60 M	135 M	43.9 M	45.9 M	40.6 M	57.5 M	9.06 M	2 M	-2.66 M	-17.5 M	-19.8 M	-15 M	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
135 M	-19.8 M	28.2 M

Quarterly Retained Earnings Penumbra

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
190 M	144 M	99.2 M	26 M	85.7 M	146 M	80.6 M	71.4 M	52.5 M	43.9 M	40 M	-	46 M	45.9 M	70.5 M	-	52.5 M	40.6 M	40.6 M	40.6 M	40.6 M	57.5 M	57.5 M	57.5 M	57.5 M	9.06 M	9.06 M	9.06 M	9.06 M	2 M	2 M	2 M	2 M	-2.66 M	-2.66 M	-2.66 M	-2.66 M	-17.5 M	-17.5 M	-17.5 M	-17.5 M	-19.8 M	-19.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
190 M	-19.8 M	36.9 M

Retained Earnings of other stocks in the Medical devices industry

Issuer	Retained Earnings	Price	% 24h	Market Cap	Country
AxoGen AXGN	-291 M	$ 33.22	1.87 %	$ 1.47 B	USA
Allied Healthcare Products AHPI	-15.7 M	-	3.58 %	$ 2.21 M	USA
Apollo Endosurgery APEN	-337 M	-	-	$ 475 M	USA
GenMark Diagnostics, Inc. GNMK	-533 M	-	-	$ 1.77 B	USA
Axonics Modulation Technologies AXNX	-374 M	-	-	$ 3.31 B	USA
Acutus Medical AFIB	-600 M	-	-26.83 %	$ 2.62 M	USA
Obalon Therapeutics, Inc. OBLN	-185 M	-	-5.86 %	$ 30.6 M	USA
Aziyo Biologics AZYO	-176 M	-	1.37 %	$ 20.5 M	USA
Cognyte Software Ltd. CGNT	-157 M	$ 7.01	2.04 %	$ 503 M	Israel
Apyx Medical Corporation APYX	-54.4 M	$ 3.76	-1.7 %	$ 130 M	USA
Alphatec Holdings ATEC	-1.28 B	$ 13.29	1.41 %	$ 1.9 B	USA
BIOLASE BIOL	-317 M	-	-13.19 %	$ 166 K	USA
Bio-Rad Laboratories BIO	7.42 B	$ 255.19	-12.51 %	$ 7.2 B	USA
Conformis CFMS	-581 M	-	-	$ 16.4 M	USA
Bruker Corporation BRKR	2.41 B	$ 36.35	-3.09 %	$ 5.42 K	USA
BioSig Technologies BSGM	-255 M	-	37.08 %	$ 85.7 M	USA
CONMED Corporation CNMD	560 M	$ 41.59	-0.28 %	$ 1.28 B	USA
Boston Scientific Corporation BSX	2.67 B	$ 74.77	0.88 %	$ 110 B	USA
Abbott Laboratories ABT	47.3 B	$ 112.22	0.66 %	$ 195 B	USA
Cardiovascular Systems CSII	-424 M	-	0.15 %	$ 844 M	USA
EDAP TMS S.A. EDAP	-82.6 M	$ 4.8	0.63 %	$ 179 M	France
Delcath Systems DCTH	-532 M	$ 9.25	1.43 %	$ 264 M	USA
Cutera CUTR	-303 M	-	-10.19 %	$ 1.99 M	USA
CryoLife, Inc. CRY	20 M	-	-4.14 %	$ 702 M	USA
ClearPoint Neuro CLPT	-191 M	$ 13.44	3.07 %	$ 363 M	USA
Electromed ELMD	21.2 M	$ 24.2	3.82 %	$ 205 M	USA
Soliton, Inc. SOLY	-70.6 M	-	-1.42 %	$ 435 M	USA
Hancock Jaffe Laboratories, Inc. HJLI	-56.2 M	-	-1.98 %	$ 98.3 M	USA
Itamar Medical Ltd. ITMR	-119 M	-	0.03 %	$ 1.58 B	Israel
Dynatronics Corporation DYNT	-40.5 M	-	14.99 %	$ 929 K	USA
Misonix, Inc. MSON	-39.3 M	-	-	$ 462 M	USA
Neovasc NVCN	-395 M	-	-	$ 111 M	Canada
Intersect ENT, Inc. XENT	-303 M	-	-	$ 955 M	USA
Eargo EAR	-514 M	-	-	$ 10.2 M	USA
Inogen INGN	-153 M	$ 5.71	-1.38 %	$ 135 M	USA
InMode Ltd. INMD	875 M	$ 14.36	0.38 %	$ 1.14 B	Israel
IRadimed Corporation IRMD	56.8 M	$ 99.81	-0.03 %	$ 1.26 B	USA
GBS GBS	-62.5 M	-	-0.57 %	$ 7.12 M	USA
Integer Holdings Corporation ITGR	891 M	$ 85.46	0.23 %	$ 2.87 B	USA
Second Sight Medical Products EYES	-122 M	-	-0.97 %	$ 54.4 M	USA
Avinger AVGR	-421 M	-	-20.74 %	$ 369 K	USA
FONAR Corporation FONR	-33.6 M	$ 18.55	0.05 %	$ 122 M	USA
Pulmonx Corporation LUNG	-468 M	$ 1.47	3.17 %	$ 57.5 M	USA
Globus Medical GMED	1.15 B	$ 87.89	0.76 %	$ 11.9 B	USA
Integra LifeSciences Holdings Corporation IART	940 M	$ 11.29	4.46 %	$ 869 M	USA
Myomo MYO	-88.8 M	$ 0.82	0.41 %	$ 5.78 M	USA
Establishment Labs Holdings ESTA	-445 M	$ 75.22	2.28 %	$ 2.12 B	Costa-rica